Physician
Dermatology
Dr. Basil M. Hantash, MD
|
|
Give Review
Basil M. Hantash works in the field of Dermatology. He researched medicine at Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76/0 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Basil Hantash is also a published doctor. He has 53 paper published. The most recent paper is: Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives. Doctor Basil M. Hantash, MD accepts all Medicare patients.
Publications
- Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem Cells.
- Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem Cells and their epidermal derivatives.
- Human embryonic stem Cell derived-mesenchymal stem Cells: an alternative mesenchymal stem Cell source for regenerative medicine therapy.
- Minireview: Peptide Analogs And Short Sequence Oligopeptides As Modulators Of Skin Pigmentation.
- Novel Pentapeptide Activators of Mammalian And Mushroom Tyrosinase.
- Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem Cells.
- Mutated HLA-G3 localizes to the Cell surface but does not inhibit cytotoxicity of natural killer Cells.
- Commentary: Gene profiling analysis of the early effects of ablative fractional carbon dioxide laser treatment on human Skin.
- ?2-Microglobulin-free HLA-G activates natural killer Cells by increasing cytotoxicity and proinflammatory cytokine production.
- Minimally invasive bipolar fractional radiofrequency treatment upregulates anti-senescence pathways.
- Isolation and cultivation of human scalp interfollicular epidermal stem Cells.
- Prospective multicenter clinical trial of a minimally invasive temperature-controlled bipolar fractional radiofrequency system for rhytid and laxity treatment.
- Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides.
- Advances in the Treatment of Melasma: A Review of the Recent Literature.
- Mesenchymal stem Cells as immunomodulator therapies for immune-mediated systemic dermatoses.
- Treatment of recalcitrant vulvovaginal gingival syndrome with adalimumab.
- The erbium micropeel: a prospective, randomized trial of the effects of two fluence settings on facial photoaging.
- TGF-?1 Regulates Differentiation of Bone Marrow Mesenchymal Stem Cells.
- Immunohistochemical evaluation of the heat shock response to nonablative fractional resurfacing.
- Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal Cells.
- Emerging technologies in aesthetic medicine.
- Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase.
- A predictive model of minimally invasive bipolar fractional radiofrequency Skin treatment.
- A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
- Pilot clinical study of a novel minimally invasive bipolar microneedle radiofrequency device.
- Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.
- Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis.
- Split-face comparison of the erbium micropeel with intense pulsed light.
- Palisaded neutrophilic and granulomatous Dermatitis associated with limited systemic sclerosis.
- Adult and fetal wound healing.
- Fractional photothermolysis: a novel aesthetic laser surgery modality.
- A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
- In vivo histological evaluation of a novel ablative fractional resurfacing device.
- Ex vivo histological characterization of a novel ablative fractional resurfacing device.
- The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing.
- De novo malignant eccrine spiradenoma: a case report and review of the literature.
- Facial resurfacing for nonmelanoma Skin cancer prophylaxis.
- Laser-induced transepidermal elimination of dermal content by fractional photothermolysis.
- Traction alopecia in children.
- Cellular regulation of sodium-calcium exchange.
- What''s new in Skin resurfacing and rejuvenation?
- Small cutaneous wounds induce telogen to anagen transition of murine hair follicle stem Cells.
- Differential expression of stem Cell markers in human follicular bulge and interfollicular epidermal compartments.
- Support of human adipose-derived mesenchymal stem Cell multipotency by a poloxamer-octapeptide hybrid hydrogel.
- Calcineurin activation by slow calcium release from intraCellular stores suppresses protein kinase C regulation of L-type calcium channels in L6 Cells.
- Mode-specific inhibition of sodium-calcium exchange during protein phosphatase blockade.
- Calcium signal transmission between ryanodine receptors and mitochondria.
- Current role of resurfacing lasers.
- Dual regulation of the cardiac L-type calcium channel in L6 Cells by protein kinase C.
- The efficacy of tetracycline antibiotics for treatment of lichen planus: an open-label clinical trial.
- Liver enzyme abnormalities in patients with Atopic dermatitis treated with mycophenolate mofetil.
- Regulation of the cardiac L-type calcium channel in L6 Cells by arginine-vasopressin.
Schools
UmdnjNew Jersey Med Sch
Procedures Preformed
- Acne Surgery
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Santa Clara Valley Medical Center -
Rutgers New Jersey Medical School
Drug Facts
| NPI NUMBER | 1942248083 | |
| NPPES Provider LastName | HANTASH | |
| NPPES Provider FirstName | BASIL | |
| NPPES Provider ZIPCode | 953821146 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1204.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942248083 |
| Last Name Of The Provider | HANTASH |
| First Name Of The Provider | BASIL |
| View All |
Similar Doctors
|
|
Dr. James M. Robinson, MD
 This Doctor is OpenDoctor Recommended.
|